Provided by Tiger Trade Technology Pte. Ltd.

Personalis

16.00
-0.0600-0.37%
Post-market: 16.000.00000.00%19:54 EDT
Volume:1.84M
Turnover:29.52M
Market Cap:1.71B
PE:-14.58
High:16.24
Open:16.19
Low:15.98
Close:16.06
52wk High:18.89
52wk Low:4.96
Shares:107.00M
Float Shares:72.63M
Volume Ratio:0.67
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.28
PE(LYR):-17.57

Loading ...

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21

Top Midday Decliners

MT Newswires Live
·
Jul 21

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

TIPRANKS
·
Jul 21

Needham Downgrades Personalis to Hold From Buy

MT Newswires Live
·
Jul 20

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Personalis (PSNL) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 20

Personalis Cut to Hold from Buy by Needham

Dow Jones
·
Jul 20

Personalis downgraded to Hold from Buy at Needham

TIPRANKS
·
Jul 20

Personalis downgraded to Hold from Buy at Lake Street

TIPRANKS
·
Jul 20

Personalis to be acquired by Tempus AI in merger

TIPRANKS
·
Jul 20

Tempus Publishes Investor Deck on Planned Personalis Acquisition to Expand MRD Testing Platform

Reuters
·
Jul 20

Sector Update: Healthcare

MT Newswires Live
·
Jul 20

Personalis trading resumes

TIPRANKS
·
Jul 20

Tempus AI Shares Fall 8.5% Premarket After Co to Acquire Personalis in $1.5 Bln Deal

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis for $1.5 Billion

Reuters
·
Jul 20

Tempus AI to acquire Personalis for $16.25 per share

TIPRANKS
·
Jul 20

Tempus AI Agrees to Buy Personalis for USD 16.25 Per Share in USD 1.5 Billion Deal

Reuters
·
Jul 20

Tempus AI Inc - Maximum Exchange Ratio Set at 0.3356 Tempus AI Shares Per Personalis Share

THOMSON REUTERS
·
Jul 20

Personalis - Deal Valued at $1.50 Bln, Personalis Shareholders to Receive $16.25 Per Share

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (mrd) into Its Ai-enabled Precision Oncology Platform

THOMSON REUTERS
·
Jul 20

NASDAQ Trade Halt Halt News Pending at 08:25 Am

Reuters
·
Jul 20